For patients with chronic kidney disease (CKD), promoting adequate self-care necessitates identification of each patient's barriers and needs based on individual characteristics including age, cohabitation, and employment ...
Oct 21, 2022
0
4
The New Zealand parliament is currently considering a new smokefree law to implement key components of the Smokefree Aotearoa 2025 Action Plan.
Oct 19, 2022
0
20
Migraine is associated with an increased risk for subsequent dementia, according to a study published online Aug. 24 in The Journal of Headache and Pain.
Oct 5, 2022
0
16
Rheumatoid arthritis (RA) is an autoimmune disease that causes extensive inflammation of the joints, causing severe pain and discomfort in patients. But did you know that the disease is also commonly accompanied by neuropsychiatric ...
Sep 28, 2022
0
16
South Korea had administered more COVID-19 vaccine doses per 100 people than other developed countries by the end of March 2022. A new article published in OMICS: A Journal of Integrative Biology presents six pivotal lessons ...
Sep 22, 2022
0
6
Researchers led by Nanyang Technological University, Singapore (NTU Singapore) have found that individuals show less trust in preventive care interventions suggested by artificial intelligence (AI) than when the same interventions ...
Sep 7, 2022
0
13
For patients with intermediate coronary stenosis being evaluated for percutaneous coronary intervention (PCI), fractional flow reserve (FFR) guidance is noninferior to intravascular ultrasonography (IVUS) guidance for a composite ...
Sep 1, 2022
0
9
Adults who increase their alcohol consumption may have a higher risk for alcohol-related cancers and all cancers versus adults who had sustained quitting or reduced levels of drinking, according to a study published online ...
Aug 25, 2022
0
13
Regular physical activity is linked to a lower risk of COVID-19 infection and severity, including hospital admission and death, finds a pooled data analysis of the available evidence, published online in the British Journal ...
Aug 22, 2022
0
287
Although Aduhelm, a monoclonal antibody targeting amyloid beta (Aβ), recently became the first US FDA approved drug for Alzheimer's disease (AD) based on its ability to decrease Aβ plaque burden in AD patients, its effect ...
Aug 4, 2022
0
42
